Pharmaceutical & Life Sciences News

Pfizer Vaccine Patent Strikes Out Again at Patent Board

June 4, 2019, 7:55 PM

A Pfizer Inc. antibacterial vaccine patent sustained another loss at the U.S. Patent and Trademark Office, this time in a challenge brought by Sanofi Pasteur Inc. and South Korean company SK Chemicals Co. LTD.

The PTO’s Patent Trial and Appeal Board June 3 found all 45 claims of U.S. Patent No. 9,492,559 unpatentable as obvious in light of prior art. The decision came in an inter partes review, a procedure in which the patentability of a patent’s claims are considered based on prior patents or printed publications.

The decision is the PTAB’s latest involving the patentability of claims in the...

To read the full article log in. To learn more about a subscription click here.